Testing effectiveness (Phase 2)Looking for participantsNCT07100704
What this trial is testing
Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab
Who this might be right for
Recurrent/ Metastatic Olfactory Neuroblastoma
National Cancer Center Hospital East 14